Hill Island Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Sell
849
-83
-9% -$17.9K 0.05% 91
2026
Q1
$203K Sell
932
-80
-8% -$17.7K 0.05% 84
2025
Q4
$231K Sell
1,012
-163
-14% -$37.1K 0.06% 73
2025
Q3
$272K Buy
1,175
+50
+4% +$10.2K 0.07% 67
2025
Q2
$209K Buy
+1,125
New +$209K 0.06% 74
2025
Q1
Sell
-1,439
Closed -$256K 60
2024
Q4
$256K Sell
1,439
-11
-0.8% -$2.02K 0.07% 63
2024
Q3
$286K Buy
1,450
+60
+4% +$11.2K 0.09% 56
2024
Q2
$238K Buy
+1,390
New +$230K 0.08% 60

Other funds holding ABBV

Hill Island Financial's ABBV Position: Q2 2026 in Review

Hill Island Financial reduced its AbbVie (ABBV) stake by 8.9% in Q2 2026, selling an estimated $17.9K and leaving 849 shares worth $214K. The position accounts for 0.05% of the portfolio, ranked #91.

Hill Island Financial first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $286K in Q3 2024. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hill Island Financial held 849 shares of AbbVie worth $214K as of Q2 2026.
  • Hill Island Financial sold 83 AbbVie shares in Q2 2026, an estimated $17.9K.
  • AbbVie made up 0.05% of Hill Island Financial's portfolio in Q2 2026, its #91 holding.
  • Hill Island Financial first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
  • Hill Island Financial's AbbVie position peaked at $286K in Q3 2024.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hill Island Financial's 13F filing for Q2 2026, filed 11 Aug 2026.